Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Clinical Trial of Neoadjuvant Zanidatamab for HER2+ Localized Colorectal Cancer

NCT07405476 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT07405476
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07405476 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Clinical Trial of Neoadjuvant Zanidatamab for HER2+ Localized Colorectal Cancer
Lead sponsor
Emory University
Phase
Phase 2
Overall status
Recruiting
Start date
April 7, 2026
Completion date
December 18, 2029
Enrollment
38 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

colon carcinoma, colorectal carcinoma, rectal carcinoma, stage i colon cancer ajcc v8, stage i colorectal cancer ajcc v8, stage i rectal cancer ajcc v8, stage ii colon cancer ajcc v8, stage ii colorectal cancer ajcc v8, stage ii rectal cancer ajcc v8, stage iii colon cancer ajcc v8, stage iii colorectal cancer ajcc v8, stage iii rectal cancer ajcc v8